Search results
Earnings call: Daiichi Sankyo posts strong FY 2023 results, plans growth By Investing.com
Investing.com· 7 days agoDaiichi Sankyo also highlighted the strategic alliances with AstraZeneca (NASDAQ:AZN) and U.S....
Victoria Atkins insists that she did not snub Covid vaccine victims
Daily Telegraph· 6 days agoVictoria Atkins was accused of ignoring members of a campaign group after her correspondence manager...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 5 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 5 days agoSource: GuruFocus Conclusion In our assessment, increased competition in the global cancer therapeutics market from Merck (NYSE:MRK) and AstraZeneca...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 4 days agoMerck & Co- $30.5bn Roche- $15.56bn (CHF 14.20bn) Johnson & Johnson- $15.09bn Novartis- $ 11.37bn AstraZeneca- $10.94bn Pfizer- $10.58bn Eli Lilly-...
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management
MedPage Today· 5 days agoThe history of primary myelofibrosis dates back to 1951 and the description of four distinct...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 6 days agoWith many pharma and biotech bigwigs having already reported results, the earnings picture has been...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
Morningstar· 5 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look ...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 6 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 3 days agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
